Parallel Advisors, LLC

SEC CIK: 0001690010
Latest filing: Aug 5, 2026

SEC filings (opens in a new tab)

HRTX holding history

Heron Therapeutics, Inc. in every 13F filed by Parallel Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

HRTX overview All 13F holders of HRTX Full Q2 2026 holdings

Shares (Q2 2026): 200
Value: $85
% of portfolio: <0.1%
Quarters held: 22; Since Q1 2021

Holdings of HRTX by Parallel Advisors, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	200	$85	<0.1%	00.0%	Unchanged	Holders
Q1 2026	200	$160	<0.1%	00.0%	Unchanged	Holders
Q4 2025	200	$260	<0.1%	00.0%	Unchanged	Holders
Q3 2025	200	$252	<0.1%	00.0%	Unchanged	Holders
Q2 2025	200	$414	<0.1%	00.0%	Unchanged	Holders
Q1 2025	200	$440	<0.1%	00.0%	Unchanged	Holders
Q4 2024	200	$306	<0.1%	00.0%	Unchanged	Holders
Q3 2024	200	$398	<0.1%	00.0%	Unchanged	Holders
Q2 2024	200	$700	<0.1%	00.0%	Unchanged	Holders
Q1 2024	200	$554	<0.1%	00.0%	Unchanged	Holders
Q4 2023	200	$340	<0.1%	00.0%	Unchanged	Holders
Q3 2023	200	$206	<0.1%	−623−75.7%	Reduced	Holders
Q2 2023	823	$955	<0.1%	00.0%	Unchanged	Holders
Q1 2023	823	$1.24K	<0.1%	+623+311.5%	Added	Holders
Q4 2022	200	$500	<0.1%	00.0%	Unchanged	Holders
Q3 2022	200	$1.00K	<0.1%	00.0%	Unchanged	Holders
Q2 2022	200	$1.00K	<0.1%	00.0%	Unchanged	Holders
Q1 2022	200	$1.00K	<0.1%	00.0%	Unchanged	Holders
Q4 2021	200	$2.00K	<0.1%	00.0%	Unchanged	Holders
Q3 2021	200	$2.00K	<0.1%	00.0%	Unchanged	Holders
Q2 2021	200	$3.00K	<0.1%	00.0%	Unchanged	Holders
Q1 2021	200	$3.00K	<0.1%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.